Neuroscience
The case for viewing depression as a consciousness disorder
A new hypothesis explains depression as an altered state of consciousness, which could help researchers make an objective diagnostic test.
First ever therapy for rare genetic disorder now approved
The FDA has approved the first drug for Rett syndrome, a genetic neurodevelopmental disorder, which disproportionately affects women and girls.
Psychedelics open a new window on the mechanisms of perception
Some neuroscientists think psychedelics and the hallucinations they induce could help reveal how we generate our perceptions of the world.
Here’s how your sleep affects your immune system
Researchers found that patients who slept less than six hours a night were 27% more likely to have an infection.
Scientists inject stem cells into the brain of Parkinson’s patient
A new stem cell therapy for Parkinson’s disease has just been administered to the brain of a person for the first time.
Cyborg fish grow electrodes in their brains and fins
A gel that turns into an electrode once inside the body might end the need for invasive implantation surgeries.
Breakthrough study discovers that psychedelics breach our neurons
Researchers have discovered that psychedelics can activate 5-HT2A receptors inside of cortical neurons, a possible cause of their therapeutic effects.
First: Spinal cord stimulation helps stroke survivors control arms again
Spinal cord stimulation has been shown to improve upper-limb mobility in stroke survivors for the first time.
DMT therapy appears effective for depression in phase 2 clinical trial
London-based Small Pharma has released positive top-line results for their phase 2a trial of DMT as an antidepressant.